Interference Test Kit

CAT: 0952-K2010001Size: 1 EachDry Ice: NoHazardous: No

1 / 1

CAT#:0952-K2010001Size:1 Each

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

Interference Test Kit

Catalog #	K2010001
Others Name(s)	Endogenous Substances Interference Test Kit
Content	Ascorbic Acid 176 mg/mL in diluent A (1 mL) Conjugated Bilirubin 20 mg/mL in diluent A (1 mL) Free Bilirubin 20 mg/mL in diluent B (1 mL) Human Hemoglobin 200 mg/mL in diluent A (1 mL) Human Serum Proteins 20 g/dL in diluent A (1 mL) Triglycerides mix 1000 mg/mL in neat solution (1 mL) Diluent A (2 mL) Diluent B (1 mL)
Storage	-20¬∞C
Open Vial Stability	One year at -20¬∞C
Applications	Testing the interference of Ascorbic Acid, Conjugated Bilirubin, Free Bilirubin, Conjugated Bilirubin, Human Hemoglobin, Human Serum Proteins and Triglycerides with assays using whole blood, serum or plasma. Adjustment of reagent composition during assay development.
Keywords	Interference, Endogenous Substances, Bilirubin, Conjugated Bilirubin, Human Hemoglobin, Triglycerides, Human Serum Proteins, Ascorbic Acid, interference testing, interfering substances kit, triglyceride interference, assay interference kits, interferent kit, interference test kits, assay interference solution

Schiettecatte, J., Anckaert, E., and Smitz, J. (2012). Interferences in Immunoassays. Advances in Immunoassay Technology.
Miller, J. J., and Levinson, S. S. (1996). Interferences In Immunoassays. Immunoassay, 165‚Äì190.
Ward, G. (2013). Rational investigations of immunoassay interferences. Pathology, 45.
Park, J. Y., and Kricka, L. J. (2013). Interferences in Immunoassay. The Immunoassay Handbook, 403‚Äì416.
EP07: Interference Testing in Clinical Chemistry. (2020). Retrieved from https://clsi.org/standards/products/method-evaluation/documents/ep07/.
Gilles A, Frechin L, Natchiar K, Biondani G, Loeffelholz OV, Holvec S, Malaval JL, Winum JY, Klaholz BP, Peyron JF. Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies. Cells. 2020 Mar 5;9(3). pii: E629.
Coussens NP, Auld D, Roby P, Walsh J, Baell JB, Kales S, Hadian K, Dahlin JL. Compound-Mediated Assay Interferences in Homogenous Proximity Assays. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-. 2020 Feb 1.

https://moleculardepot.com/product/interference-test-kit-extra-for-assay-validation/

Short Description

Weight

Length

2.5

Width

Height

1.2

Related Products

Catalog	Name
K2010009	HAMA Interference Kit
K2010007	Rheumatoid Factor Interference Kit
C2010423	Riboflavin for Interference Testing
K2010008I	Intralipid for Interference Testing
K2010008G1	Glucose for Interference Testing
K2010008P	Pyruvate for Interference Testing
C2010416	Galactose for Interference Testing
C2010418	Ethanol for Interference Testing
C2010401	Acetone for Interference Testing
K2010008G2	Glycerol for Interference Testing

Catalog	Name
INT-04	ASSURANCE™ Drug Interference Test Kit PN
INT-04CYC	ASSURANCE™ Drug Interference Test Kit for Cyclosporine**
INT-04MED	ASSURANCE™ Drug Interference Test Kit for Methyldopa
INT-01B	ASSURANCE™ Interference Test Kit for Conjugated Bilirubin
INT-04PHE	ASSURANCE™ Drug Interference Test Kit for Phenylbutazone**
INT-01BU-01	ASSURANCE™ Interference Test Kit for Unconjugated Bilirubin
INT-04HEP	ASSURANCE™ Drug Interference Test Kit for Heparin
INT-04ACM	ASSURANCE™ Drug Interference Test Kit for Acetaminophen
INT-04THE	ASSURANCE™ Drug Interference Test Kit for Theophylline
INT-04IBU	ASSURANCE™ Drug Interference Test Kit for Ibuprofen**